CAS 1906205-76-2

Iladatuzumab

CAS : 1906205-76-2

Iladatuzumab (MCDS0593A) is a monoclonal antibody targeting CD79B with potential anticancer activity for the study of B-cell non-Hodgkin's lymphoma (B-NHL).

Degré de pureté : 98.7% (SDS-PAGE); 98.9% (SEC-HPLC) - 98.7% (SDS-PAGE); 98.9% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 145.3 kDa

Ref: TM-T82078

Iladatuzumab

CAS : 1906205-76-2

A humanized IgG1 monoclonal antibody against CD79 B.

Ref: 3D-CLA1495